jrnl5598

Publication Venue For

  • Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor.  17:2099-2109. 2019
  • Human neutrophil peptide-1 inhibits thrombus formation under arterial flow via its terminal free cysteine thiols.  17:596-606. 2019
  • Mechanisms and mitigating factors for venous thromboembolism in chronic kidney disease: the REGARDS study.  16:1743-1752. 2018
  • Hemostasis biomarkers and incident cognitive impairment: the REGARDS study.  16:1259-1267. 2018
  • Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score.  15:2184-2187. 2017
  • Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.  15:1889-1900. 2017
  • Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study.  15:1086-1094. 2017
  • Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity: comment.  15:586-589. 2017
  • Association of stroke risk biomarkers with stroke symptoms: the Reasons for Geographic and Racial Differences in Stroke cohort.  15:21-27. 2017
  • Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A.  15:110-121. 2017
  • Hemostasis biomarkers and risk of sepsis: the REGARDS cohort.  14:2169-2176. 2016
  • Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease.  13:1064-1072. 2015
  • C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts.  12:1667-1677. 2014
  • ABO blood type and stroke risk: The REasons for Geographic And Racial Differences in Stroke Study.  12:564-570. 2014
  • Inflammation markers and incident venous thromboembolism: The REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.  12:1993-2001. 2014
  • Structure-function and regulation of ADAMTS-13 protease.  11:11-23. 2013
  • Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells.  8:2001-2010. 2010
  • Von Willebrand factor cleaved from endothelial cells by ADAMTS13 remains ultralarge in size.  7:1749-1752. 2009
  • Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time.  7:80-86. 2009
  • Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells.  6:1233-1235. 2008
  • Quercetin induced tissue-type plasminogen activator expression is mediated through Sp1 and p38 mitogen-activated protein kinase in human endothelial cells.  6:976-985. 2008
  • Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.  4:1707-1717. 2006
  • Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: The Coronary Artery Risk Development in Young Adults (CARDIA) study.  4:1279-1287. 2006
  • An evaluation of cyclosporine alone for the treatment of early recurrences of thombotic thrombocytopenic purpura.  4:1162-1164. 2006
  • Function-blocking antithrombospondin-1 monoclonal antibodies.  4:459-468. 2006